Stepwise	O
activation	O
of	O
enhancer	O
and	O
promoter	O
regions	O
of	O
the	O
B	B-TISSUE
cell	E-TISSUE
commitment	O
gene	O
Pax5	O
in	O
early	O
lymphopoiesis	O
.	O


Pax5	O
is	O
an	O
essential	O
regulator	O
of	O
B	B-TISSUE
cell	E-TISSUE
identity	O
and	O
function	O
.	O


Here	O
,	O
we	O
used	O
transgenesis	O
and	O
deletion	O
mapping	O
to	O
identify	O
a	O
potent	O
enhancer	O
in	O
intron	O
5	O
of	O
the	O
Pax5	O
locus	O
.	O


This	O
enhancer	O
in	O
combination	O
with	O
the	O
promoter	O
region	O
was	O
sufficient	O
to	O
recapitulate	O
the	O
B	B-TISSUE
lymphoid	E-TISSUE
expression	O
of	O
Pax5	O
.	O


The	O
enhancer	O
was	O
silenced	O
by	O
DNA	O
methylation	O
in	O
embryonic	B-TISSUE
stem	I-TISSUE
cells	E-TISSUE
,	O
but	O
became	O
activated	O
in	O
multipotent	O
hematopoietic	B-TISSUE
progenitors	E-TISSUE
.	O


It	O
contained	O
functional	O
binding	O
sites	O
for	O
the	O
transcription	O
factors	O
PU	O
.	O
1	O
,	O
IRF4	O
,	O
IRF8	O
,	O
and	O
NF	O
-	O
kappaB	O
,	O
suggesting	O
that	O
these	O
regulators	O
contribute	O
to	O
sequential	O
enhancer	O
activation	O
in	O
hematopoietic	B-TISSUE
progenitors	E-TISSUE
and	O
during	O
B	B-TISSUE
cell	E-TISSUE
development	O
.	O


In	O
contrast	O
,	O
the	O
promoter	O
region	O
was	O
repressed	O
by	O
Polycomb	O
group	O
proteins	O
in	O
non	O
-	O
B	B-TISSUE
cells	E-TISSUE
and	O
was	O
activated	O
only	O
at	O
the	O
onset	O
of	O
pro	B-TISSUE
-	I-TISSUE
B	I-TISSUE
cell	E-TISSUE
development	O
through	O
induction	O
of	O
chromatin	O
remodeling	O
by	O
the	O
transcription	O
factor	O
EBF1	O
.	O


These	O
experiments	O
demonstrate	O
a	O
stepwise	O
activation	O
of	O
Pax5	O
in	O
early	O
lymphopoiesis	O
and	O
provide	O
mechanistic	O
insights	O
into	O
the	O
process	O
of	O
B	B-TISSUE
cell	E-TISSUE
commitment	O
.	O
